CAPROCK Group, Inc.

SEC CIK: 0001610769
Latest filing: Jul 27, 2026

SEC filings (opens in a new tab)

NVO holding history

Novo Nordisk A S in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overview All 13F holders of NVO Full Q2 2026 holdings

Shares (Q2 2026): 45,422
Value: $2.18M
% of portfolio: <0.1%
Quarters held: 20; Since Q1 2021

Holdings of NVO by CAPROCK Group, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	45,422	$2.18M	<0.1%	+3,585+8.6%	Added	Holders
Q1 2026	41,837	$1.59M	<0.1%	−2,260−5.1%	Reduced	Holders
Q4 2025	44,097	$2.24M	<0.1%	−5,208−10.6%	Reduced	Holders
Q3 2025	49,305	$2.78M	0.1%	–	No prior filing	Holders
Q2 2025	–	–	–	–	Not filed	Holders
Q1 2025	60,404	$4.26M	0.1%	−1,861−3.0%	Reduced	Holders
Q4 2024	62,265	$5.36M	0.2%	+1,013+1.7%	Added	Holders
Q3 2024	61,252	$7.29M	0.3%	+61,252	New	Holders
Q2 2024	0	$0	0.0%	−28,215−100.0%	Sold out	Holders
Q1 2024	28,215	$3.65M	0.2%	−3,402−10.8%	Reduced	Holders
Q4 2023	31,617	$3.27M	0.2%	−2,762−8.0%	Reduced	Holders
Q3 2023	34,379	$3.13M	0.2%	+947+2.8%	AddedConverted for a 2-for-1 split	Holders
Q2 2023	16,716	$2.71M	0.2%	+449+2.8%	Added	Holders
Q1 2023	16,267	$2.61M	0.2%	−1,288−7.3%	Reduced	Holders
Q4 2022	17,555	$2.38M	0.2%	+260+1.5%	Added	Holders
Q3 2022	17,295	$1.72M	0.2%	+978+6.0%	Added	Holders
Q2 2022	16,317	$1.82M	0.2%	−523−3.1%	Reduced	Holders
Q1 2022	16,840	$1.89M	0.2%	−404−2.3%	Reduced	Holders
Q4 2021	17,244	$1.93M	0.2%	−428−2.4%	Reduced	Holders
Q3 2021	17,672	$1.70M	0.2%	−4,902−21.7%	Reduced	Holders
Q2 2021	22,574	$1.89M	0.2%	−320−1.4%	Reduced	Holders
Q1 2021	22,894	$1.56M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.